Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer’s disease
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer’s disease
Authors
Keywords
Clusterin, Alzheimer’s disease, LRP-2, Amyloid
Journal
BMC NEUROSCIENCE
Volume 19, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-01-26
DOI
10.1186/s12868-018-0402-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clusterin Binds to Aβ1–42Oligomers with High Affinity and Interferes with Peptide Aggregation by Inhibiting Primary and Secondary Nucleation
- (2016) Marten Beeg et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Three dimensions of the amyloid hypothesis: time, space and 'wingmen'
- (2015) Erik S Musiek et al. NATURE NEUROSCIENCE
- Clusterin/Apolipoprotein J immunoreactivity is associated with white matter damage in cerebral small vessel diseases
- (2015) Lucinda Craggs et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- New Therapeutic Approaches for Alzheimer’s Disease and Cerebral Amyloid Angiopathy
- (2014) Satoshi Saito et al. Frontiers in Aging Neuroscience
- Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force
- (2013) Bruno Vellas et al. Alzheimers & Dementia
- Animal models of asthma: Reprise or reboot?
- (2013) Kevin Mullane et al. BIOCHEMICAL PHARMACOLOGY
- The Role of Clusterin in Amyloid-β–Associated Neurodegeneration
- (2013) Rahul S. Desikan et al. JAMA Neurology
- What does complement do in Alzheimer’s disease? Old molecules with new insights
- (2013) Yong Shen et al. Translational Neurodegeneration
- Association Study of Clusterin Polymorphism rs11136000 With Late Onset Alzheimer’s Disease in Chinese Han Population
- (2012) Jian-Fang Ma et al. American Journal of Alzheimers Disease and Other Dementias
- Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
- (2012) Henrik Zetterberg ARCHIVES OF NEUROLOGY
- LRP1 in Brain Vascular Smooth Muscle Cells Mediates Local Clearance of Alzheimer's Amyloid-
- (2012) T. Kanekiyo et al. JOURNAL OF NEUROSCIENCE
- Clusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt–PCP–JNK pathway
- (2012) R Killick et al. MOLECULAR PSYCHIATRY
- Plasma Clusterin and the Risk of Alzheimer Disease
- (2011) Elisabeth M. C. Schrijvers JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β1−40 peptide
- (2011) Priyanka Narayan et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Plasma clusterin concentration is associated with longitudinal brain atrophy in mild cognitive impairment
- (2011) Madhav Thambisetty et al. NEUROIMAGE
- Association of Plasma Clusterin Concentration With Severity, Pathology, and Progression in Alzheimer Disease
- (2010) Madhav Thambisetty et al. ARCHIVES OF GENERAL PSYCHIATRY
- Replication of CLU, CR1, and PICALM Associations With Alzheimer Disease
- (2010) Minerva M. Carrasquillo et al. ARCHIVES OF NEUROLOGY
- Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes
- (2010) Gyungah Jun ARCHIVES OF NEUROLOGY
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- Clusterin: A forgotten player in Alzheimer's disease
- (2009) Tapio Nuutinen et al. BRAIN RESEARCH REVIEWS
- Clearance of Amyloid-β Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimers Disease
- (2009) R. Deane et al. CNS & Neurological Disorders-Drug Targets
- Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
- (2009) Jean-Charles Lambert et al. NATURE GENETICS
- Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
- (2009) Denise Harold et al. NATURE GENETICS
- Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice
- (2009) V. Echeverria et al. NEUROSCIENCE
- Intracerebroventricular amyloid- antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice
- (2009) D. R. Thakker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New therapeutic targets in the neurovascular pathway in Alzheimer’s disease
- (2008) Berislav V. Zlokovic Neurotherapeutics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search